CASC
Cascadian Therapeutics, Inc.
CASC
CASC
Delisted
CASC was delisted on the 8th of March, 2018.
100 hedge funds and large institutions have $211M invested in Cascadian Therapeutics, Inc. in 2015 Q2 according to their latest regulatory filings, with 27 funds opening new positions, 38 increasing their positions, 22 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
11% more funds holding
Funds holding: 90 → 100 (+10)
Holders
100
Holding in Top 10
3
Calls
$2.99M
Puts
$1.74M
Top Buyers
| 1 | +$15.6M | |
| 2 | +$9.06M | |
| 3 | +$4.21M | |
| 4 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$2.51M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.65M |
Top Sellers
| 1 | -$17.1M | |
| 2 | -$14.4M | |
| 3 | -$6.73M | |
| 4 |
D.E. Shaw & Co
New York
|
-$2.37M |
| 5 |
First Eagle Investment Management
New York
|
-$2.12M |